BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19135930)

  • 1. The role of single-photon emission computed tomography/computed tomography for precise localization of metastases in patients with differentiated thyroid cancer.
    Wang H; Fu HL; Li JN; Zou RJ; Gu ZH; Wu JC
    Clin Imaging; 2009; 33(1):49-54. PubMed ID: 19135930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
    Ingui CJ; Shah NP; Oates ME
    Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
    Wong KK; Cahill JM; Frey KA; Avram AM
    Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR; Obuchowski NA; Difilippo FP
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
    Pérault C; Schvartz C; Wampach H; Liehn JC; Delisle MJ
    J Nucl Med; 1997 Aug; 38(8):1234-42. PubMed ID: 9255157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
    Kim SJ; Lee TH; Kim IJ; Kim YK
    Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT.
    Qiu ZL; Xu YH; Song HJ; Luo QY
    Head Neck; 2011 Feb; 33(2):171-7. PubMed ID: 20848436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal metastases from follicular thyroid cancer on SPECT/CT.
    von Falck C; Beer G; Gratz KF; Galanski M
    Clin Nucl Med; 2007 Sep; 32(9):751-2. PubMed ID: 17710039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
    Schillaci O
    Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection.
    Lazzeri E; Erba P; Perri M; Doria R; Tascini C; Mariani G
    Clin Nucl Med; 2010 Jan; 35(1):12-7. PubMed ID: 20026965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.
    Römer W; Nömayr A; Uder M; Bautz W; Kuwert T
    J Nucl Med; 2006 Jul; 47(7):1102-6. PubMed ID: 16818944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images.
    Kizu H; Takayama T; Tsushima H; Noguchi A; Nakajima K; Onoguchi M; Kinuya S
    J Nucl Med Technol; 2008 Dec; 36(4):186-8. PubMed ID: 19008288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.
    Ruf J; Steffen I; Mehl S; Rosner C; Denecke T; Pape UF; Plotkin M; Amthauer H
    Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular functional analysis with 16- and 64-row multidetector computed tomography: comparison with gated single-photon emission computed tomography.
    Agarwal PP; Patel S; Corbett J; Jung JI; Barber K; Schipper M; Kazerooni EA
    J Comput Assist Tomogr; 2009; 33(1):8-14. PubMed ID: 19188778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.